Gore Announces First Implant of Next Generation Conformable GORE TAG
Cytos Biotechnology updates on the development of the hypertension vaccine CYT006-AngQb
CardiacAssist expands market penetration of TandemHeart
Cardiogenesis Reports Third Quarter 2009 Results
Gore Receives European CE Mark Approval for Next Generation Conformable GORE TAG
To keep up to date with news from this category use our ![]()
Gore Receives European CE Mark Approval for Next Generation Conformable GORE TAG
7 November 2009 (Flagstaff, Arizona) - W.L. Gore & Associates (Gore) today announced that it has received European CE Mark approval for the next generation GORE TAG
CardiacAssist expands market penetration of TandemHeart
PITTSBURGH, Nov. 2, 2009--Privately held CardiacAssist Inc. announced today that the Cardiovascular Institute of Stanford (University) Hospital & Clinics (Palo Alto, Calif.) is one of the newest cardiac centers to begin...
Endologix Reports 47% Third Quarter 2009 Revenue Growth
IRVINE, Calif., October 27, 2009 -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, today announced financial results for the three and nine months ended September 30,...
ORTHO CLINICAL DIAGNOSTICS LAUNCHES FETALSCREEN(TM) II FETAL MATERNAL HEMORRHAGE SCREENING TEST
RARITAN, N.J. (Oct. 23, 2009) - Ortho Clinical Diagnostics announced the launch of FETALSCREEN(TM) II Fetal Maternal Hemorrhage Screening Test, a simple, qualitative test that detects D (Rho) positive fetal red blood...
Gore Announces First Implant of Next Generation Conformable GORE TAG
October 20, 2009--W. L. Gore & Associates (Gore) today announced the first human implants of the next generation Conformable GORE TAG
CathRx announces commencement of pilot trial for its irrigated ablation catheter
Sydney 17 June 2009: Cardiac catheter manufacturer CathRx Ltd (ASX: CXD) today announced it had commenced a human pilot trial of its first therapeutic catheter for use in both atrial flutter and atrial fibrillation...